1. 2018
  2. A site-specific radiolabelling strategy of Nanobodies for PET imaging

    Bridoux, J., Broos, K., Crauwels, M., Lecocq, Q., Martin, C., Cleeren, F., Bormans, G., Ballet, S., Caveliers, V., Raes, G., Breckpot, K., Muyldermans, S., Devoogdt, N., Keyaerts, M. & Xavier, C., 28 Feb 2018.

    Research output: Unpublished contribution to conferencePoster

  3. Discovery of potent NMUR1 selective Neuromedin U analogs with increased resistance against biodegradation

    De Prins, A., Martin, C., Van Wanseele, Y., Tömböly, C., Tourwe, D., Caveliers, V., Van Eeckhaut, A., Holst, B., Rosenkilde, M. M., Smolders, I. & Ballet, S., 28 Feb 2018, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  4. Development of potent and proteolytically stable human neuromedin U receptor agonists

    De Prins, A., Martin, C., Van Wanseele, Y., Skov, L. J., Tömböly, C., Tourwe, D., Caveliers, V., Van Eeckhaut, A., Holst, B., Rosenkilde, M. M., Smolders, I. & Ballet, S., 20 Jan 2018, In : European Journal of Medicinal Chemistry. 144, p. 887-897 11 p.

    Research output: Contribution to journalArticle

  5. A new powerful compact cyclotron

    Bertrand, S., Vaneycken, I., Lahoutte, T., Covens, P., Caveliers, V., Kral, E., Geets, J-M., Nactergal, B., Ghyoot, M. & Devillet, F., 2018, In : Journal of Nuclear Medicine. 59, 12, p. 2106-2106 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)

  6. Quantification of 131I activity in mouse kidney tissues using micro-SPECT/CT: a phantom study

    Saldarriaga Vargas, C., Struelens, L., Defrise, M., D'Huyvetter, M., Caveliers, V. & Covens, P., 2018.

    Research output: Unpublished contribution to conferencePoster

  7. 2017
  8. Antimicrobial peptides in frog poisons constitute a molecular toxin delivery system against predators

    Raaymakers, C., Verbrugghe, E., Hernot, S., Hellebuyck, T., Betti, C., Peleman, C., Claeys, M., Bert, W., Caveliers, V., Ballet, S., Martel, A., Pasmans, F. & Roelants, K., 14 Nov 2017, In : Nature Communications. 8, 1, p. 1495 1495.

    Research output: Contribution to journalArticle

  9. Bismuth-213 labeled nanobodies as a new treatment approach in Targeted Alpha Therapy

    Dekempeneer, Y. . J., Maertens, D., Gysemans, M., Lahoutte, T., D'Huyvetter, M., Cardinaels, T. & Caveliers, V., Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, p. S136-S136

    Research output: Contribution to journalMeeting abstract (Journal)

  10. Preclinical evaluation of astatinated nanobodies for targeted alpha therapy

    Dekempeneer, Y. D., D'Huyvetter, M., Aneheim, E., Xavier, C., Lahoutte, T., Back, T., Jensen, H., Caveliers, V. & Lindegren, S., Oct 2017, In : European Journal of Nuclear Medicine and Molecular Imaging. 44, p. S133-S134

    Research output: Contribution to journalMeeting abstract (Journal)

  11. I-131-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment

    D'Huyvetter, M., De Vos, J., Xavier, C., Pruszynski, M., Sterckx, Y. G. J., Massa, S., Raes, G., Caveliers, V., Zalutsky, M., Lahoutte, T. & Devoogdt, N., 27 Jul 2017, In : Clinical Cancer Research. 23, 21, p. 6616-6628 13 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 157891